TipRanks
Iradimed Corp (DE:46K)
FRANKFURT:46K
Germany Market
46K
Iradimed
RESEARCH TOOLSreports

Iradimed (46K) Income Statement

0 Followers

Iradimed Income Statement

Last quarter (Q2 2026), Iradimed's total revenue was $20.47M, an increase of 0.28% from the same quarter last year. In Q2, Iradimed's net income was $5.22M. See Iradimed’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 83.81M$ 73.24M$ 65.56M$ 53.30M$ 41.81M
Gross Profit
$ 64.32M$ 56.35M$ 50.16M$ 41.28M$ 32.05M
Operating Expenses
$ 38.18M$ 34.39M$ 30.12M$ 25.65M$ 22.23M
Depreciation and Amortization
$ 2.38M$ 817.66K$ 765.18K$ 670.67K$ 1.41M
EBITDA
$ 30.74M$ 25.09M$ 22.50M$ 16.85M$ 11.24M
Operating Income
$ 26.15M$ 21.96M$ 20.04M$ 15.63M$ 9.82M
Other Income/Expenses
$ 2.21M$ 2.31M$ 1.70M$ 553.10K$ 18.61K
Pretax Income
$ 28.36M$ 24.28M$ 21.74M$ 16.18M$ 9.84M
Net Income
$ 22.48M$ 19.23M$ 17.19M$ 12.83M$ 9.33M
Per Share Metrics
Basic EPS
$ 1.77$ 1.52$ 1.36$ 1.02$ 0.76
Diluted EPS
$ 1.75$ 1.50$ 1.35$ 1.02$ 0.74
Weighted Average Shares Outstanding
 12.72M 12.67M 12.60M 12.56M 12.35M
Weighted Average Shares Outstanding (Diluted)
 12.85M 12.78M 12.72M 12.64M 12.59M
Currency in USD

Iradimed Earnings and Revenue History